Skip to NavigationSkip to content

News

Novartis has declared new findings for Entresto, showing that the drug proved itself superior to enalapril-a in patients with heart failure with...
Public Health England is urging the public to ensure that they have received two doses of the MMR vaccine after it was revealed that there were...
A combination of chemotherapy drug azacitidine and nivolumab (Bristol-Myers Squibb’s Opdivo) has proven effective in treating patients with...
AstraZeneca has jettisoned another non-essential asset with the sale of Synagis (palivizumab), a preventative treatment for infections relating to...
Shares in Korean firm Samsung BioLogics plummeted this week, falling by as much as 20% on Monday, after the South Korean Securities and Futures...
MSD’s blockbuster immunotherapy Keytruda has secured another FDA approval, this time for the treatment of hepatocellular carcinoma (HCC) in...
Food and Drug Administration (FDA) commissioner Scott Gottlieb has said that if a more rigorous approval process is introduced for opioids, the...
AstraZeneca has revealed new data for its sodium-glucose co-transporter 2 (SGLT2) inhibitor Farxiga (dapagliflozin) at the American Heart...
The UK government’s request that pharmaceutical companies stockpile an additional six weeks’ worth of medicine, in preparation for a no-deal Brexit...
Hundreds have died in a recent outbreak of Ebola in the Democratic Republic of Congo (DRC), in what has been described as the worst outbreak in the...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches